NAD+

Every batch ships with a batch code printed on the vial. The matching independent lab report — identity, purity, and composition — independently lab-tested results — is linked on the product page and also available from your order page after purchase.

We recommend it — especially if you are pregnant, nursing, managing a medical condition, or combining peptides with prescribed medication. Our product pages are educational. They are not medical advice and they do not replace a conversation with a qualified practitioner.

Sensitive peptides ship cold. Move them to a fridge on arrival (2–8 °C) unless the product page states otherwise. Lyophilised vials can tolerate short transit at ambient temperature but should not be left unrefrigerated for extended periods once delivered.

Strictly, no — NAD+ (nicotinamide adenine dinucleotide) is a dinucleotide coenzyme, not a chain of amino acids. It is often grouped with peptide therapies in clinic menus because the delivery format (subcutaneous or IV) and the longevity-research framing overlap, but biochemically it is a different class of molecule.

Oral NAD+ is poorly absorbed intact, so most oral supplements use precursors — NR (nicotinamide riboside) or NMN (nicotinamide mononucleotide) — which the body converts to NAD+. Subcutaneous and IV NAD+ bypass first-pass metabolism and produce measurable plasma elevations in published pharmacokinetic work.

Bring both the lyophilised vial and the bacteriostatic water to room temperature, equalise pressure with a sterile vented needle, then inject the solvent slowly down the side of the vial. Swirl gently — never shake — until clear, and refrigerate at 2–8 °C.

The calculation is peptide mass (mg) ÷ desired concentration (mg/mL) = volume of bacteriostatic water in mL. For example, a 5 mg vial at 1 mg/mL needs 5 mL; at 2 mg/mL, 2.5 mL. Every Peptyds product page carries a suggested reconstitution volume tuned to the vial size.

Most lyophilised peptides reconstituted with bacteriostatic water remain stable for 28–30 days at 2–8 °C, protected from light. A handful of short, fragile sequences — Epithalon among them — drop to roughly 14 days. Never freeze a reconstituted vial.

Across published trials and case series, the most frequent reported events are injection-site reactions (redness, induration, transient discomfort), headache, mild nausea, and temporary fatigue. GLP-1 and dual-agonist class peptides add dose-dependent gastrointestinal effects.

Peptides are not appropriate for anyone who is pregnant, nursing, planning conception, under 18, managing active cancer, or on immunosuppressants — and competitive athletes governed by WADA must avoid every peptide on the prohibited list. Anyone with a personal or family history of melanoma should specifically avoid melanocortin-receptor agonists.